TickerFacts.

Pacira BioSciences, Inc. (PCRX): Share Repurchases

Annual figures by period end, from SEC filings.

$148.33M
Year ended 2025-12-31
$148.33M
Trailing 12 months to 2026-06-30
2010-12-31: $2.0K2022-12-31: $02023-12-31: $02024-12-31: $25.00M2025-12-31: $148.33M$148.33M
2010-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$148.33M+493.3%2026-02-26, From 2025-01-01
2024-12-31$25.00Mn/a2026-02-26, From 2024-01-01
2023-12-31$0n/a2026-02-26, From 2023-01-01
2022-12-31$0n/a2025-02-27, From 2022-01-01
No annual figure between 2010-12-31 and 2022-12-31.
2010-12-31$2.0Kn/a2013-03-07, From 2010-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Pacira BioSciences, Inc. (PCRX)2025-12-31$148.33M+493.3%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$75.59M-11.6%
Emergent BioSolutions Inc. (EBS)2025-12-31$24.90Mn/a
Corcept Therapeutics Inc (CORT)2025-12-31$172.91Mn/m
Collegium Pharmaceutical, Inc (COLL)2025-12-31$25.10M-58.2%
Opko Health, Inc. (OPK)2025-12-31$47.04M-47.9%
ANI Pharmaceuticals Inc (ANIP)2025-12-31$12.21M+11.4%
Organogenesis Holdings Inc. (ORGO)2024-12-31$25.48Mn/a
HUTCHMED (China) Ltd (HCM)2024-12-31$36.06M+297.6%

Compare PCRX, AMPH, EBS, CORT side by side · Screen every company in Pharmaceutical Preparations ↗